SUNY
Biotia Raises $8M in Series A Financing
The New York-based startup said the funding will be used to expand its technical capabilities, regulatory compliance, and marketing reach.
Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion
The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children.
Quadrant Biosciences Licenses SUNY, Penn State Epigenetic Biomarkers for Neuro Diseases
The company hopes to develop saliva-based RNA assays for concussion, Parkinson's disease and autism using biomarkers discovered by its two academic partners.